Novel small molecule potently attenuates neuroinflammation in brain and glial cells

In a preclinical study show that their small molecule drug, SRI-42127, can potently attenuate the triggers of neuroinflammation. These experiments in glial cell cultures and mice now open the door to testing SRI-42127 in models of acute and chronic neurological injury.


Click here for original story, Novel small molecule potently attenuates neuroinflammation in brain and glial cells


Source: ScienceDaily